|
ALL over
the world, cervical cancer kills more than 300,000
women, and 500,000 new cases are diagnosed each year.
It is the second most common killer of women in the
Asia-Pacific region, where a woman loses her life to the
disease every four minutes. In the Philippines, 6,000
women develop cervical cancer annually and an estimated
4,300 of them die from the disease. Two-thirds of these
cases are diagnosed in the advanced stages, when
mortality is high, and 56 percent of them will die
within five years from the time of diagnosis.
Cervical
cancer is caused by the Human Papillomavirus (HPV).
There are over 100 different viruses with at least 30
strains known to cause different types of cancer. HPV is
transmitted by skin-to-skin contact through vaginal,
anal or oral sex with a partner who already has HPV. If
infected, signs and symptoms may take weeks, months or
years to appear or not at all. HPV normally appears in
the form of genital warts that look like cauliflower or,
sometimes, flat growths. They can be found inside and
outside the vagina.
Those
who have a high risk of contracting the disease are
women with previous cervical dysplasia; those with
numerous sexual partners, or whose male sexual partners
have had other sexual partners who ultimately developed
cervical neoplasia; women who began having sexual
intercourse at an early age; women with current or prior
HPV infection or condylomata; women with a history of
smoking or abuse of other substances; those with a
weakened immune system; and women who have given birth
to many children.
“All
women are at risk of developing cervical cancer,” said
Professor Cecilia Ladines-Llave, chairman of the Cancer
Institute, University of Philippines-Philippine General
Hospital, vice president of the Asia-Oceania Research
Organization in Genital Infection and Neoplasia
Philippines, and program director of the Cervical Cancer
Prevention Network Alliance Program in the Philippines.
“While
most HPV infections clear up naturally, some remain and
may develop changes in the cervical cells that may lead
to cervical cancer, often after many years and without
warning signs,” Llave added.
“The
risk of cervical cancer increases with age, affecting
women at the prime of their lives, usually between the
age of 30 and 50 years, often while they are working and
still responsible for children or other family members,”
added Dr. Diane Harper, professor of the Department of
Women’s and Gender Studies, Dartmouth College, and
Department of Obstetrics/Gynecology and Community &
Family Medicine, Dartmouth Medical School, in Hanover,
New Hampshire, and a director of gynecological
cancer-prevention research at Norris Cotton Cancer
Center in Lebanon.
The sad
news is there is no cure for this killer. The good news
is that it can be prevented. GlaxoSmithKline
Philippines
recently announced the availability of its cervical
cancer vaccine, called Cervarix, which is indicated in
both young and older women (10 years of age onwards) for
the prevention of cervical cancer. It is the first
vaccine proven to provide 100-percent protection against
HPV types 16 and 18, which together are responsible for
over 70 percent of cervical-cancer cases in the
Asia-Pacific region. It has also shown efficacy against
persistent infection caused by other oncogenic HPV
types. Cervarix is the only vaccine that has been
formulated using the innovative adjuvant system called
AS04, which is designed to enhance immune response and
increase the duration of protection against
cancer-causing HPV types.
The
primary vaccination course for Cervarix consists of
three doses, given at zero, one and six months, and the
vaccine can be given to girls as young as 10 or before
the onset of sexual activity.
Women
may also reduce the risk of developing cervical cancer
by getting regular Pap smears, limiting themselves to
one sexual partner, using a condom, quitting smoking or
avoiding secondhand smoke. |